UPDATE: UBS Starts Infoblox (BLOX) at Buy; Leader in Strong Growth Market
Get Alerts BLOX Hot Sheet
Price: $13.00 -0.15%
Rating Summary:
5 Buy, 10 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 10 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
(Updated - May 22, 2012 4:12 PM EDT)
UBS initiates coverage on Infoblox (NYSE: BLOX) with a Buy. PT $21.00.
Analyst, Nikos Theodosopoulos, said, "BLOX has grown at a 40% CAGR, growing sales from $35M to ~$133M over the last four years. Industry analysts estimate the size of the DDI market at ~$290M in 2011 growing 29% to $380M in 2012...As the DDI market leader, we believe Infoblox is attractively positioned to grow its business at a 15%+ long-term CAGR, will increase its profitability, has a strong management team and is exposed to growing awareness and networking trends such as SDN/OpenFlow, Cloud computing, Virtualization and BYOD."
For an analyst ratings summary and ratings history on Infoblox click here. For more ratings news on Infoblox click here.
Shares of Infoblox closed at $17.84 yesterday.
UBS initiates coverage on Infoblox (NYSE: BLOX) with a Buy. PT $21.00.
Analyst, Nikos Theodosopoulos, said, "BLOX has grown at a 40% CAGR, growing sales from $35M to ~$133M over the last four years. Industry analysts estimate the size of the DDI market at ~$290M in 2011 growing 29% to $380M in 2012...As the DDI market leader, we believe Infoblox is attractively positioned to grow its business at a 15%+ long-term CAGR, will increase its profitability, has a strong management team and is exposed to growing awareness and networking trends such as SDN/OpenFlow, Cloud computing, Virtualization and BYOD."
For an analyst ratings summary and ratings history on Infoblox click here. For more ratings news on Infoblox click here.
Shares of Infoblox closed at $17.84 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share